A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

New England Journal of Medicine

Volumn 359, Issue 9, 2008, Pages 895-905

  Rouse, Dwight J ^a,y   Hirtz, Deborah G ^b   Thom, Elizabeth ^c   Varner, Michael W ^d   Spong, Catherine Y ^e   Mercer, Brian M ^f,g   Iams, Jay D ^h   Wapner, Ronald J ^i,j   Sorokin, Yoram ^k   Alexander, James M ^l   Harper, Margaret ^m   Thorp Jr , John M ⁿ   Ramin, Susan M ^o   Malone, Fergal D ^p   Carpenter, Marshall ^q   Miodovnik, Menachem ^r   Moawad, Atef ^s   O'Sullivan, Mary J ^t   Peaceman, Alan M ^u   Hankins, Gary D V ^v   Langer, Oded ^w   Caritis, Steve N ^x   Roberts, James M ^x   more..

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ THOMAS JEFFERSON UNIVERSITY   (United States)

^j DREXEL UNIVERSITY   (United States)

^k WAYNE STATE UNIVERSITY   (United States)

^l UNIVERSITY OF TEXAS AT DALLAS   (United States)

^m WAKE FOREST UNIVERSITY   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o UNIVERSITY OF TEXAS   (United States)

^p Och Spine at New York Presbyterian Hospitals   (United States)

^q BROWN UNIVERSITY   (United States)

^r UNIVERSITY OF CINCINNATI   (United States)

^s UNIVERSITY OF CHICAGO   (United States)

^t UNIVERSITY OF MIAMI   (United States)

^u NORTHWESTERN UNIVERSITY   (United States)

^v UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^w UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^x UNIVERSITY OF PITTSBURGH   (United States)

^y OHB 457 ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; PLACEBO;

ADULT; ARTICLE; CEREBRAL PALSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 50449093260     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0801187     Document Type: Article

References (33)

1. Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005;47:571-6.
2. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med 1994;330:188-95.
3. Cummins SK, Nelson KB, Grether JK, Veile EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr 1993;123:230-7.
4. Robertson CMT, Watt M-J, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely in a population-based program over 30 years. JAMA 2007;297:2733-40.
5. Tommiska V, Heinonen K, Lehtonen L, et al. No improvement in outcome of nationwide extremely low birthweight infant populations between 1996-1997 and 1999-2000. Pediatrics 2007;119:29-36.
6. Vincer MJ, Allen AC, Joseph KS, Stinson DA, Scott H, Wood E. Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics 2006;118(6):e1621-e1626.
7. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002;110:1220-5.
8. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9.
9. Hirtz DG, Nelson KN. Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr 1998;10:131-7.
10. Hallak M, Berry SM, Madincea F, Romero R, Evans MI, Cotton DB. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol 1993;81:185-8.
11. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-40.
12. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9:345-64. [Erratum, Control Clin Trials 1989;10:following 126.]
13. Nelson KB, Ellenberg JH. Children who "outgrew" cerebral palsy. Pediatrics 1982;69:529-36.
14. Capute AJ, Shapiro BK. The motor quotient: a method for the early detection of motor delay. Am J Dis Child 1985;139:940-2.
15. Blasco PA. Primitive reflexes: their contribution to the early detection of cerebral palsy. Clin Pediatr (Phila) 1994;33:388-97.
16. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23.
17. Bayley N. Bayley scales of infant development. 2nd ed. New York: Psychological Corporation, 1993.
18. Stevenson RE, Hall JG. Terminology. In: Stevenson RE, Hall JD, Goodman RM, eds. Human malformations and related anomalies. Oxford, England: Oxford University Press, 1993:21-30.
19. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. JAMA 1997;278:989-95.
20. Pinto-Martin JA, Riolo S, Cnaan A, Holzman C, Susser MW, Paneth N. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics 1995;95:249-54. [Erratum, Pediatrics 2001;108:238.]
21. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
22. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003;290:2669-76.
23. Marret S, Marpeau L, Follet-Bouhamed C, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008;36:278-88. (In French.)
24. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997;350:1517-8.
25. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-8.
26. Grether J, Hirtz D, McNellis D, Nelson K, Rouse DJ. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998;351:292.
27. Rouse DJ, Hirtz DG, Thom E. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2003;188:295.
28. Crowther C, Hiller J, Doyle L, Lumley J, Carlin J. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998;351:291.
29. Leveno KJ. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998;351:291-2.
30. Bénichou J, Zupan V, Fernandez H, Marpeau L, Marret S. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998;351:290-1.
31. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia: outcome for children at 18 months. BJOG 2007;114:289-99.
32. Montori VM, Permanyear-Miralda G, Ferreira-González I, et al. Validity of composite end points in clinical trials. BMJ 2005;330:594-6.
33. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Magnesium sulfate for preterm neuroprotection. JAMA 2004;291:941.